Chromatographic Society of India with SIES Institute of Chromatography and Spectroscopy to organise…
Seminar on chromatographic techniques in pharma API will be beneficial for chemists working with pharma companies, graduates and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
More effective drugs for diabetes in the offing
Working in mice, the researchers showed they could reduce glucose production in the liver and lower blood sugar levels
Scientists…
Carbopol Workshop
Lubrizol LifeSciences will conduct Carbopol polymer workshop for oral formulations
Aurobindo Pharma receives US FDA approval for Telmisartan tabs
Telmisartan tablets are indicated in the treatment of essential hypertension
Kamani Oil Industries receives FDA license
The facility in Khopoli was recently inspected
Kamani Oil Industries has received a FDA drug license for manufacture of…
Hetero issues official statement on US business
The company statement went on to underline that InvaGen Pharmaceuticals is not linked directly to the flagship companies of the…
Cipla to acquire US-based InvaGen Pharmaceuticals and Exelan Pharmaceuticals
Signs agreements to acquire 100 per cent of generic businesses in the US for $550 million
Cipla's UK arm, Cipla EU has entered…
Indian Immunologicals organises workshop
The workshop provided insights into the impact of climate change on infectious disease patterns, in human and animal populations…
Lupin launches Duloxetine 40mg delayed-release capsules in US
Lupin has launched Duloxetine 40mg delayed-release capsules. The company has earlier launched Duloxetine HCl DR capsules 20 mg, 30…
Glenmark’s novel monoclonal antibody GBR 830 to enter phase II clinical studies
GBR 830 targets activated T cells, which drives the pathology in most autoimmune diseases including rheumatoid arthritis, multiple…